Max Healthcare Institute Limited (MAXHEALTH.BO)
INR 1196.5
(0.28%)
INR 1196.5
(0.28%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 16.7 Billion INR | 7.78% |
| 2022 | 13.79 Billion INR | 27.74% |
| 2021 | 10.6 Billion INR | 95.59% |
| 2020 | 2.84 Billion INR | 305.42% |
| 2019 | 1.41 Billion INR | -34.29% |
| 2018 | 2.12 Billion INR | 28.04% |
| 2017 | 1.67 Billion INR | -22.01% |
| 2016 | 1.82 Billion INR | 55.15% |
| 2015 | 1.4 Billion INR | 515.59% |
| 2014 | 218.1 Million INR | -22.99% |
| 2013 | 283.2 Million INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 3.87 Billion INR | -9.22% |
| 2023 Q1 | 3.78 Billion INR | -1.69% |
| 2023 FY | - INR | 7.78% |
| 2023 Q4 | 3.81 Billion INR | -11.66% |
| 2023 Q3 | 4.31 Billion INR | -0.22% |
| 2023 Q2 | 4.32 Billion INR | 14.29% |
| 2022 Q3 | 3.58 Billion INR | 4.02% |
| 2022 Q2 | 3.44 Billion INR | 16.52% |
| 2022 Q4 | 3.85 Billion INR | 7.42% |
| 2022 FY | - INR | 27.74% |
| 2022 Q1 | 2.95 Billion INR | 18.89% |
| 2021 Q3 | 2.94 Billion INR | 8.91% |
| 2021 Q4 | 2.48 Billion INR | -15.48% |
| 2021 Q1 | 2.7 Billion INR | 16.3% |
| 2021 FY | - INR | 95.59% |
| 2021 Q2 | 2.7 Billion INR | 0.08% |
| 2020 Q2 | 1.27 Billion INR | 2577.43% |
| 2020 Q4 | 2.32 Billion INR | 16.34% |
| 2020 Q3 | 1.99 Billion INR | 56.78% |
| 2020 Q1 | -51.4 Million INR | -101.97% |
| 2020 FY | - INR | 305.42% |
| 2019 FY | - INR | -34.29% |
| 2019 Q4 | 2.61 Billion INR | 707.42% |
| 2019 Q2 | 313.1 Million INR | -50.18% |
| 2019 Q3 | 323.3 Million INR | 3.26% |
| 2019 Q1 | 628.42 Million INR | 45.14% |
| 2018 Q1 | 146.05 Million INR | 0.0% |
| 2018 FY | - INR | 28.04% |
| 2018 Q4 | 432.97 Million INR | 0.55% |
| 2018 Q3 | 430.6 Million INR | -14.91% |
| 2018 Q2 | 506.05 Million INR | 246.49% |
| 2017 Q1 | 548.77 Million INR | 0.0% |
| 2017 FY | - INR | -22.01% |
| 2016 FY | - INR | 55.15% |
| 2015 FY | - INR | 515.59% |
| 2014 FY | - INR | -22.99% |
| 2013 FY | - INR | 0.0% |